KEI Europe comments on the EU’s cancer roadmap
KEI Europe response to the European Union’s cancer roadmap 3 March 2020 Cell and gene therapies are among the more promising innovations to treat cancer. Chimeric Antigen Receptor T-Cell (“CAR T” or “CAR T-cell”) treatments involve a combination of procedures that take place both in and outside of the body. Blood is taken from a …